遠大醫藥(00512.HK)與溫醫大眼視光醫院簽技術和知識產權轉讓協定 涉7,000萬人幣
遠大醫藥(00512.HK)公布,與溫州醫科大學附屬眼視光醫院簽訂戰略合作協定,雙方將通過資源分享、合作研發、協同創新等方法,在眼科藥物研發領域全方位深度合作。
集團亦將根據研發進度分階段支付7,000萬元人民幣,以取得溫醫大眼視光醫院用於近視防治的技術和新型眼用制劑(GPN00884)產品在大中華區範圍內的技術及知識產權權益,而後續會根據相關產品銷售情況支付若干銷售提成費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.